Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients
Daniel G. Camblor, Daniel Miranda, Guillermo M. Albaiceta, Laura Amado‐Rodríguez, Elías Cuesta‐Llavona, Daniel Vázquez‐Coto, Julia Gómez de Oña, Claudia García-Lago, Juan Gómez, Eliécer Coto
Topics & Concepts
GenotypeSepsisGenetic predispositionCoronavirus disease 2019 (COVID-19)Genetic variationGeneImmunologyMedicineNFKB1BiologyInternal medicineGeneticsDiseaseTranscription factorInfectious disease (medical specialty)NF-κB Signaling PathwaysInflammasome and immune disordersImmune Response and Inflammation